arrow
A

Andreas Hagen Røssevold

Oslo University Hospital
H指数:7
被引数:384

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials

免疫检查点抑制剂治疗的转移性乳腺癌患者的循环肿瘤细胞-ALICE和ICON试验的生物标志物分析

2024-07-085
OAAI
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial

Ipilimumab和nivolumab联合蒽环类化疗治疗转移性激素受体阳性乳腺癌: 一项随机2b期试验

2024-01-193
OAAI
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
2022-12-0841
OAAI
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
2019-12-03128
OAAI